Phase II Study of HMPL-004 in Subjects With Crohn's Disease
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
A double blind, randomized, multi-center, placebo-controlled study to evaluate the efficacy
and safety of HMPL-004 in patients with active moderate Crohn's Disease.